Observational Study of Vision Improvement in Patients With Retinal Disorders
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 54
- 试验地点
- 1
- 主要终点
- CDVA
研究概览
简要总结
The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders who received corneal treatments by a low vision aid device.
详细描述
The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders, including age-related macular degeneration and diabetic macular edema, who received corneal treatments by a low vision aid device. Patient records will be analyzed to determine measures of vision improvement including best spectacle-corrected distance visual acuity (CDVA). Analyses will include descriptive statistics and correlation between outcomes and baseline characteristics.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 50 Years 至 100 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Female or male
- •Patient is at least 50 years old
- •Patient has diagnosed retinal disorder that causes central vision loss in one or both eyes
- •Treated eyes, at time of treatment, were pseudophakic or phakic with no significant vision loss due to cataract
- •Patient had moderate to severe baseline vision impairment with CDVA of 20/63 or worse (decimal = 0.317 or less; logMAR greater than or equal to 0.50) in the treated eye(s)
- •Patient CDVA records are available at baseline and at 1m or longer post-Tx times
排除标准
- •1 - Corneal disease or disorder in either eye 2 - Increased intraocular pressure (above 20mm Hg), glaucoma or history of glaucoma 3 - Presence or history of any other condition or finding that, in the opinion of the investigator, makes the patient unsuitable for retrospective observational study
结局指标
主要结局
CDVA
时间窗: 12 months
Best spectacle-corrected distance visual acuity
次要结局
未报告次要终点
